Europe Newborn Screening Market - Industry Trends and Forecast to 2026

  • In Vitro Diagnostics
  • Published Report
  • Oct 2019
  • Europe
  • 350 Pages
  • No of Tables: 103
  • No of Figures: 25

Europe Newborn Screening Market By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test), Product Type (Instruments, Reagents and Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays and Enzymatic Assays, Electrophoresis, DNA-Based Assays), Disease Type (Critical Congenital Heart Diseases, Newborn Hearing Loss, Sickle Cell Disease, Phenylketonuria (PKU), Cystic Fibrosis (CF), Maple Syrup Urine Disease, Others), End User (Hospital, Paediatric Clinics, Clinics), Country (Germany, France, U.K., Spain, Italy, Switzerland, Netherlands, Russia, Turkey, Belgium, Rest of Europe) - Industry Trends and Forecast to 2026

Europe market for newborn screening is considered to be one of the most expanding markets in the global healthcare industry. Newborn screening is the testing that diagnoses harmful and fatal disorders in newborns which can adversely affect their long term health. The newborn screening tests can detect around thirty metabolic and genetic diseases and some common are phenylketonuria (PKU), congenital hypothyroidism (CH), galactosemia (GAL), and sickle cell disease. Increased government initiatives to aware people regarding newborn screening are playing a vital role in expansion of newborn screening market. Newborn screening is a mandatory test in over 60 countries.

Europe newborn screening market is projected to register a healthy CAGR in the forecast period of 2019 to 2026.

SegmentationEurope Newborn Screening Market

Europe newborn screening market is segmented into five notable segments which are test type, product type, technology, disease type and end user.

  • On the basis of test type, the market is segmented into dried blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test
  • On the basis of product type, the market is segmented into instruments, reagents & assay kits
  • On the basis of technology, the market is segmented into tandem mass spectrometry, hearing screen technology, pulse oximetry screening technology, immunoassays and enzymatic assays, electrophoresis, DNA-based assays
  • On the basis of disease type, the market is segmented into phenylketonuria (PKU), cystic fibrosis (CF), sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease, others
  • On the basis of end user, the market is segmented into pediatric clinics, hospital, clinics

Competitive Analysis: Europe Newborn Screening Market

Some of the major players operating in the Europe newborn screening market are PerkinElmer Inc., Natus Medical Incorporated, Trivitron Healthcare, Baebies, Inc., Bio-Rad Laboratories, Inc., Danahar, Hill-Rom Services Inc., Intelligent Hearing Systems, Interacoustics A/S, Masimo, Medtronic, Otodynamics Ltd, Vivosonic Inc., ZenTech S.A., among others.

Recent Developments

  • In October 2018, Zentech S.A. will be attending ISNS in Bratislava which had benn involved in newborn screening. The event comprises of meeting the congress and other newborn sectors for technical and scientific exchange which is beneficial for the newborn screening at early stage to support the proximity of various kind of diseases in the newborn at an early stage.
  • In July 2018, Zentech S.A. specialized in the production, development and commercialization, announced the agreement under which Zentech will transfer its RIA products to DIA source. The agreement has reoriented to focus on newborn screening and early stage diseases in order to support minimum disruption for customers.
  • In February 2015, ZenTech S.A. collaborated with Virion-Serion. This partnership combines the newborn screening assays of ZenTech with the SERION ELISA analyser, Immunomat. This agreement offers reliable automated system to the end users of ZenTech for newborn screening.

Research Methodology: Europe Newborn Screening Market

Primary Respondents: Key Opinion Leaders (KOL’s): Doctors, Nurses, Research Institutes and Medical Professionals. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE 1 NEWBORN SCREENING PROGRAM (2015 & 2016) IN THE U.S.

TABLE 2 NEONATAL MORTALITY RATE (DEATHS PER 1,000 LIVE BIRTHS), IN BETWEEN 2015 -2018

TABLE 3 PREVALENCE OF DISORDERS AMONG FILIPINO NEWBORNS (1996-2016)

TABLE 4 NUMBER OF BIRTHS IN NORTHERN HEMISPHERE (2018)

TABLE 5 PREVALENCE OF DISORDERS AMONG NORTHERN HEMISPHERE (2018)

TABLE 6 COSTS OF NEXT GENENARATION SEQUENCING DEVICES (USD MILLION)

TABLE 7 HEALTHCARE EXPENDITURE IN ASIA PACIFIC (USD MILLION)

TABLE 8 COMPARISON OF THE ECONOMIC PROSPERITY AND ANNUAL PERCENTAGE OF NEWBORN BABIES SCREENED IN SELECTED DEVELOPING NATIONS

TABLE 9 EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 10 EUROPE DRIED BLOOD SPOT TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 EUROPE HEARING SCREEN TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 12 EUROPE CRITICAL CONGENITAL HEART DISEASES TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 14 EUROPE PRODUCT IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 EUROPE INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 16 EUROPE REAGENTS AND ASSAY KITS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 18 EUROPE TANDEM MASS SPECTROMETRY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 EUROPE HEARING SCREEN TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 EUROPE PULSE OXIMETRY SCREENING TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 EUROPE IMMUNOASSAYS AND ENZYMATIC ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 EUROPE ELECTROPHORESIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 EUROPE DNA-BASED ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 EUROPE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 25 EUROPE CRITICAL CONGENITAL HEART DISEASES IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 EUROPE NEWBORN HEARING LOSS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 EUROPE SICKLE CELL DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 EUROPE PHENYLKETONURIA IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 EUROPE CYSTIC FIBROSIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 EUROPE MAPLE SYRUP URINE DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 EUROPE OTHERS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 EUROPE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 33 EUROPE HOSPITAL IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 EUROPE PEDIATRIC CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 EUROPE CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 36 EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 37 EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 38 EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 39 EUROPE INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 40 EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 41 EUROPE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 42 EUROPE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 43 GERMANY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 44 GERMANY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 45 GERMANY INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 46 GERMANY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 47 GERMANY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 48 GERMANY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 49 FRANCE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 50 FRANCE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 51 FRANCE INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 52 FRANCE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 53 FRANCE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 54 FRANCE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 55 U.K. NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 56 U.K. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 57 U.K. INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 58 U.K. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 59 U.K. NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 60 U.K. NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 61 SPAIN NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 62 SPAIN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 63 SPAIN INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 64 SPAIN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 65 SPAIN NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 66 SPAIN NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 67 ITALY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 68 ITALY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 69 ITALY INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 70 ITALY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 71 ITALY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 72 ITALY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 73 SWITZERLAND NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 74 SWITZERLAND NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 75 SWITZERLAND INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 76 SWITZERLAND NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 77 SWITZERLAND NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 78 SWITZERLAND NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 79 NETHERLANDS NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 80 NETHERLANDS NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 81 NETHERLANDS INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 82 NETHERLANDS NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 83 NETHERLANDS NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 84 NETHERLANDS NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 85 RUSSIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 86 RUSSIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 87 RUSSIA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 88 RUSSIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 89 RUSSIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 90 RUSSIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 91 TURKEY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 92 TURKEY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 93 TURKEY INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 94 TURKEY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 95 TURKEY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 96 TURKEY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 97 BELGIUM NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 98 BELGIUM NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 99 BELGIUM INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 100 BELGIUM NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 101 BELGIUM NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 102 BELGIUM NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 103 REST OF EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions